In 2025, the landmark CHALLENGE trial revealed that exercise can be as effective as medication in preventing cancer recurrence in colorectal cancer (CRC). New research presented at the 2026 ASCO Gastrointestinal Cancers Symposium continues to highlight the benefits of exercise. The results? Walking can be a powerful way to combat fatigue and boost quality of […]

According to research on colorectal cancer (CRC) outcomes, recurrence affects a significant percentage of patients after initial treatment, most commonly within the first two to three years. Recurrence doesn’t mean you’re out of options. New, targeted therapies are changing the treatment landscape. Recurrent CRC means cancer has returned after a period of remission. It can […]

For people living with HER2-positive metastatic colorectal cancer (CRC), treatment options can feel limited, especially when standard chemotherapy stops working. But new research presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting offers encouraging news: a targeted therapy called trastuzumab deruxtecan (Enhertu) may help patients live longer than standard chemotherapy, particularly when […]

A cancer diagnosis completely upends your life. One day, everything is normal and you’re following your typical routine. The next, you’re managing appointments, scans, and procedures. It’s very easy to fall into feelings of despair or depression. In fact, that’s very normal. In fact, research shows that up to 47% of cancer patients experience significant […]